Table 3 Comparison of Vasculitis Damage Index (VDI) with respect to demographic and clinical manifestations
VDI score | |||
|---|---|---|---|
Minimun-Maximum | Median (IQR) | P-value | |
Sex | |||
Male | 1–10 | 3 (2) | 0.1* |
Female | 1–7 | 5 (2) | |
Oral ulcers | |||
Yes | 1–10 | 3 (3) | 0.21* |
No | 1–3 | 3 (1) | |
Genital ulcers | |||
Yes | 1–10 | 3 (3) | 0.487* |
No | 1–8 | 3 (2) | |
Other skin lesions | |||
Yes | 1–8 | 3 (3) | 0.197* |
No | 1–10 | 3 (2) | |
Vascular involvement | |||
Yes | 1–10 | 4 (3) | 0.073* |
No | 1–7 | 3 (2) | |
DVT attacks | |||
Yes | 1–8 | 4 (3) | 0.566* |
No | 1–10 | 3 (2) | |
Arterial or venous thrombosis | |||
Yes | 1–10 | 4 (3) | 0.022* |
No | 1–8 | 3 (2) | |
Aneurysm | |||
Yes | 1–8 | 3 (2) | 0.539* |
No | 1–10 | 3 (2) | |
Neurological affection | |||
Yes | 3–10 | 5 (2) | < 0.0001* |
No | 1–8 | 3 (2) | |
Cranial nerve affection | |||
Yes | 5–10 | 6 (3) | < 0.0001* |
No | 1–8 | 3 (2) | |
Ataxia | |||
Yes | 4–7 | 4*** | 0.102* |
No | 1–10 | 5 (2) | |
Stroke | |||
Yes | 3–6 | 4 (1) | 0.014* |
No | 1–10 | 3 (2) | |
Arthritis | |||
Yes | 1–8 | 4 (1) | 0.741* |
No | 1–10 | 3 (2) | |
AVN | |||
Yes | 3–10 | 7 (7) | 0.015* |
No | 1–8 | 3 (2) | |
Osteoporosis | |||
Yes | 3–10 | 7 (7) | 0.01* |
No | 1–8 | 4 (1) | |
Uveitis | |||
Yes | 1–10 | 4 (3) | 0.005* |
No | 1–8 | 3 (2) | |
Vision | |||
Normal | 1–8 | 2 (1) | < 0.0001** |
Impaired | 1–7 | 3 (2) | |
Blindness | 2–10 | 5 (5) | |
Cataract | |||
No involvement | 1–8 | 2 (2) | < 0.0001** |
Single eye involvement | 3–10 | 5 (4) | |
Both eye involvement | 2–7 | 4 (2) | |
Diabetes | |||
Yes | 3–10 | 4 (4) | 0.012* |
No | 1–8 | 3 (2) | |